Bionano Genomics, Inc.
BNGO
$3.77
-$0.08-2.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.27% | -20.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.27% | -20.90% | |||
| Cost of Revenue | -7.47% | -25.85% | |||
| Gross Profit | 18.35% | -14.02% | |||
| SG&A Expenses | -7.61% | 955.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.61% | 64.41% | |||
| Operating Income | 7.86% | -827.16% | |||
| Income Before Tax | -121.23% | 84.62% | |||
| Income Tax Expenses | 42.86% | 600.00% | |||
| Earnings from Continuing Operations | -121.05% | 84.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -121.05% | 84.59% | |||
| EBIT | 7.86% | -827.16% | |||
| EBITDA | 10.22% | -548.95% | |||
| EPS Basic | -73.07% | 90.58% | |||
| Normalized Basic EPS | -73.20% | 66.93% | |||
| EPS Diluted | -73.07% | 90.58% | |||
| Normalized Diluted EPS | -73.20% | 66.93% | |||
| Average Basic Shares Outstanding | 27.73% | 63.61% | |||
| Average Diluted Shares Outstanding | 27.73% | 63.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||